Helicobacter pyloriand Progressive Gastric Pathology that Predisposes to Gastric Cancer
- 1 January 1991
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 26 (sup181) , 51-57
- https://doi.org/10.3109/00365529109093208
Abstract
Evidence is presented suggesting that infection by Helicobacter pylori triggers and continuously contributes to the pathophysiology of progressive gastric changes that can ultimately lead to gastric cancer. In Peru, especially in population groups of low socioeconomic status, infection by H. pylori begins earlier in life and is more prevalent and persistent than in developed countries. The infection produces a destructive lesion of the mucinous surface epithelium which probably enables other aggressive luminal factors to cause further mucosal damage. As a consequence, active chronic gastritis appears. The gastritis is of the superficial type at the beginning but may progressively change to atrophic. Chronic atrophic gastritis is found more frequently and at a younger age in dyspeptic patients with low socioeconomic status--that is, in patients having higher prevalence of persistent infection by H. pylori since earlier in life. When chronic atrophic gastritis becomes severe and extensive, hypochlorhydria ensues. Hypochlorhydria favors the appearance of bacterial overgrowth, nitrites, and N-nitroso compounds in the gastric lumen. N-nitroso compounds, because of their mutagenic-carcinogenic properties, probably induce gastric premalignant lesions like intestinal metaplasia and dysplasia of the gastric mucosa. Oral bismuth therapy apparently reverses H. pylori-associated gastric dysplasia. It is proposed that future programs designed for the control of gastric cancer would be incomplete if they do not include further evaluation of the many effects of infection by H. pylori on the gastric mucosa and of cost-effective methods to eradicate the infection.Keywords
This publication has 11 references indexed in Scilit:
- Modulation of gastric acid secretion by hypnosisGastroenterology, 1989
- Nitrofurans in the treatment of gastritis associated with Campylobacter pyloriGastroenterology, 1988
- Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrityBiochemical and Biophysical Research Communications, 1987
- High Incidence of Campylobacter-Like Organisms in Endoscopic Biopsies from Patients with Gastritis, with or without Peptic UlcerDigestion, 1987
- Campylobacter pyloridisin Peptic Ulcer Disease: I. Gastric and Duodenal Infection Caused byC. pyloridis:Histopathologic and Microbiologic FindingsScandinavian Journal of Gastroenterology, 1987
- Campylobacter-Like Organisms in Chronic Gastritis, Peptic Ulcer, and Gastric CarcinomaScandinavian Journal of Gastroenterology, 1986
- Campylobacter pyloridis, gastritis, and peptic ulceration.Journal of Clinical Pathology, 1986
- Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy.Journal of Clinical Pathology, 1986
- Histopathology of gastric dysplasias Correlations with gastric juice chemistryThe American Journal of Surgical Pathology, 1979
- A MODEL FOR GASTRIC CANCER EPIDEMIOLOGYThe Lancet, 1975